Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Germline PALB2-mutated triple negative breast cancer treated with Olaparib in a kidney transplant patient

Olaparib, a poly(ADP-ribose) polymerase inhibitor, is a commonly used agent in the treatment of human epidermal growth factor receptor 2–negative metastatic breast cancer carrying germline BRCA1/2 pathogenic variants. Phase II evidence has demonstrated antitumor activity in patients with partner and localizer of BRCA2...

Gabriel Ci En Loke, Chin H. Toh, S. Liew et al. · 0 citations
Open access Oct 2026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

The aim is to provide guidance for the optimisation and harmonisation of the management of patients with RCC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials.

R. Kanesvaran, V. Gruenwald, A. Wong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.